The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000419.5(ITGA2B):c.1439+8C>T

CA8603095

323556 (ClinVar)

Gene: ITGA2B
Condition: Glanzmann thrombasthenia
Inheritance Mode: Autosomal recessive inheritance
UUID: ead95400-b086-4056-9b56-0f80a148246e
Approved on: 2024-11-07
Published on: 2024-11-07

HGVS expressions

NM_000419.5:c.1439+8C>T
NM_000419.5(ITGA2B):c.1439+8C>T
NC_000017.11:g.44380592G>A
CM000679.2:g.44380592G>A
NC_000017.10:g.42457960G>A
CM000679.1:g.42457960G>A
NC_000017.9:g.39813486G>A
NG_008331.1:g.13914C>T
ENST00000262407.6:c.1439+8C>T
ENST00000648408.1:c.870+8C>T
ENST00000262407.5:c.1439+8C>T
ENST00000592226.5:n.912+8C>T
ENST00000592462.5:n.234+8C>T
NM_000419.3:c.1439+8C>T
NM_000419.4:c.1439+8C>T
More

Uncertain Significance

Not Met criteria codes 15
BP2 BP7 PS2 PS3 BA1 PP4 PP1 PP3 PM6 PM2 PM3 BS2 BS4 BS3 BS1

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Platelet Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2.1

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Platelet Disorders VCEP
The c.1439+8C>T variant in ITGA2B is an intronic variant located in intron 14 of 28. The highest population minor allele frequency in gnomAD v4.1.0 is 0.002770(82/29608 alleles) in the Ashkenazi Jewish population, which is higher than the threshold (<0.0001) for PM2_Supporting. The highest continental population minor allele frequency in gnomAD v4.1.0 is 0.000009322 (11/1180044 alleles) in the European (non-Finnish) population, which is below the BS1 threshold of >0.00158. This intronic variant is not predicted by SpliceAI to impact splicing with a score of 0.01. However, BP7 was not applied because the nucleotide is highly conserved, as shown by phyloP score of 1.9773. In summary, this variant meets the criteria to be classified as a variant of uncertain significance for autosomal recessive Glanzmann Thrombasthenia based on the lack of ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP.
Not Met criteria codes
BP2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BP7
The c.1439+8C>T is an intronic variant that is not predicted by SpliceAI to impact splicing with a score of 0.01. However, BP7 was not applied because the nucleotide is highly conserved, as shown by phyloP score of 1.9773.
PS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BA1
The highest population minor allele frequency in gnomAD v4.1.0 is 0.002770 (82/29608 alleles) in the Ashkenazi Jewish population. It would meet the BA1 (>0.0024) threshold, however bottle-necked populations are not considered for BS1 or BA1. The next highest population minor allele frequency in gnomAD v4.1.0 is 0.000009322 (11/1180044 alleles) in the European (non-Finnish) population.
PP4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PP3
The computational predictor REVEL has no data. And the computational splicing predictor SpliceAI indicated that the variant has no predicted impact on splicing with a score of 0.01.
PM6
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM2
The highest population minor allele frequency in gnomAD v4.1.0 is 0.002770 (82/29608 alleles) in the Ashkenazi Jewish population. This is higher than the threshold (<0.0001) for PM2_Supporting.
PM3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS4
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.